The availability and activity of NO are constrained by metabolic competition within the tumor microenvironment; notably, cancer cells compete for large amounts of L-arginine, which limits substrate availability for endothelial nitric oxide synthase (eNOS). Here, NOS3 is linked to neoplasm.